Treatmentexperimental

Phosphatidylcholine IV (PC / Plaquex)

Intravenous infusion of phosphatidylcholine (a phospholipid), marketed under names like Plaquex for cellular membrane 'repair', cardiovascular/plaque support, cognitive health, and anti-aging.

Evidence

experimental

Evidence is limited to older, low-quality studies (mostly for liver conditions and fat-embolism prophylaxis) with no credible controlled trials supporting the marketed anti-aging, cognitive, or plaque-reversal longevity claims.

Regulatory notes

European Union
Injectable phospholipid products are prescription medicines in some EU countries (liver indications) but IV use for anti-aging/plaque is off-label and marketing claims are restricted.
United States
Not FDA-approved for cardiovascular, cognitive, or anti-aging use; typically administered as a compounded off-label infusion under physician supervision.
United Arab Emirates
Restricted to DHA/DoH-licensed physicians; off-label anti-aging use is regulatory-sensitive and disease claims are prohibited.
United Kingdom
Prescription-only injectable used off-label; the MHRA does not approve it for anti-aging or plaque reversal and claims are restricted.

General information, not medical or legal advice. See our disclaimer.

Also known as

PC IV, Plaquex, phospholipid IV, essential phospholipids infusion, lipid exchange therapy, PhosChol IV

Where to find it

72 clinics in the directory offer phosphatidylcholine iv (pc / plaquex). Prices shown are the cheapest for this treatment where published; always confirm with the venue.

London

Back to glossary